Scarica l'app Stockscreener
0.4169
6.19%
-0.0275
Dopo l'orario di chiusura:
.41
-0.0069
-1.66%
VolitionRX Ltd Borsa (VNRX) Ultime notizie
VolitionRX Ltd (VNRX) (Q2 2026) Earnings Call Highlights: Strate - GuruFocus
Benchmark reiterates Hold on VolitionRX stock amid cost cuts - Investing.com
Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com Canada
VNRX Looks 97.6% Undervalued on GF Value™ - GuruFocus
Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G - Stock Titan
Teleconferência de Resultados do 2º Trimestre de 2026 da VolitionRx (VNRX): Custos Caem à Medida que o Pipeline Nu.Q Avança - TradingKey
Conferencia de resultados del Q2 de 2026 de VolitionRx (VNRX): los costos caen a medida que avanza la cartera de desarrollo de Nu.Q - TradingKey
VolitionRx (VNRX) Q2 2026 Ergebniskonferenz: Kosten sinken bei Fortschritten der Nu.Q-Pipeline - TradingKey
Volitionrx Ltd earnings beat by $0.06, revenue fell short of estimates - Investing.com Canada
Transcript : VolitionRx Limited, Q2 2026 Earnings Call, Aug 14, 2026 - marketscreener.com
Earnings call transcript: VolitionRX misses Q2 2026 estimates as shares slip - Investing.com Canada
VolitionRX Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
VolitionRx Limited Q2 2026 Earnings Call Summary - Yahoo Finance
VolitionRx Q2 Revenue Flat, but Licensing Talks and $5M Milestone Ahead - Minichart
VNRX|VolitionRX Ltd|Price:0.537|Chg%:-0.101 - TradingKey
VolitionRX: Q2 Earnings Snapshot - marketscreener.com
VolitionRx Q2 2026: Operating expenses fall 32% to $4.6 million - scanx.trade
Form 8K Volitionrx Ltd For: 13 August By Investing.com - Investing.com Nigeria
VolitionRx (VNRX) flags going concern risk amid $14M loss and NYSE plan - Stock Titan
VolitionRx Limited (NYSE: VNRX) doubles H1 2026 revenue and trims losses - Stock Titan
VolitionRx Limited Announces Second Quarter 2026 Financial Results and Business Update - Moomoo
Earnings To Watch: VolitionRX Ltd (VNRX) Q2 2026 -- GF Value Sees 3914% Upside - Yahoo Finance
VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK
VolitionRx tests finger-prick sepsis prototype in patients - Investing.com Nigeria
VolitionRx tests finger-prick sepsis prototype in patients By Investing.com - Investing.com Australia
VolitionRx Limited Demonstrates Utility of Rapid Point-Of-Care Finger-Prick Test in Sepsis Patients - marketscreener.com
VolitionRx call will cover Q2 results and upcoming milestones - Stock Titan
VolitionRx Limited Schedules Second Quarter 2026 Earnings Conference Call and Business Update - Yahoo Finance
5 Stocks To BUY HEAVY In Early August 2026 Cat Deeley (ii210v0TXj) - Mshale
VolitionRX Ltd (VNRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
VolitionRx issues 779,371 shares to Lind Global to meet convertible note obligations - Bitget
Volition's early liquid biopsy study detected 49 of 49 cancers - Stock Titan
VolitionRx publishes Capture-Seq paper targeting $36B market - scanx.trade
VolitionRx targets $3.8B sepsis market with Nu.Q NETs platform - scanx.trade
VolitionRX Ltd (VNRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
VolitionRX Ltd (VNRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VolitionRX Ltd (VNRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
VolitionRX Ltd (VNRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
VolitionRX Ltd (VNRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
VNRX|VolitionRX Ltd|Price:0.890|Chg%:-0.110 - TradingKey
VolitionRX Ltd (VNRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VolitionRX Ltd (VNRX) Balance Sheet - tradingkey.com
VolitionRX Ltd (VNRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
VNRX|VolitionRX Ltd|Price:1.000|Chg%:-0.070 - TradingKey
TradingKey - TradingKey
VolitionRx Limited Amends Certificate of Incorporation: SEC Filing Details and XBRL Data 10 - Minichart
VOLITIONRX LTD SEC Filing (Jul 20, 2026) - Stock Titan
VolitionRx (VNRX) Stock Gets Fair Value Boost As Analysts Split On Nu.Q Execution - Yahoo Finance
VolitionRX (VNRX) Registration filing Summary - Quartr
VNRX Announces Sale of 3.31 Million Shares by Selling Stockholders - GuruFocus
VolitionRx (NYSE: VNRX) files to register 3.3M Lind-linked shares for resale - Stock Titan
Maxim Group Maintains VolitionRX(VNRX.US) With Buy Rating, Maintains Target Price $4 - Moomoo
VolitionRx Ltd explores blood-based cancer diagnostics as investors watch VNRX - ad-hoc-news.de
VolitionRx releases lung cancer prognostic study data - Investing.com
VolitionRx releases lung cancer prognostic study data By Investing.com - Investing.com Australia
VolitionRx’s lung cancer test could help doctors predict outcomes - Stock Titan
VolitionRx data shows Nu.Q test predicts lung cancer outcomes - scanx.trade
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):